PTIX: Protagenic Therapeutics, Inc. Stock

by  •  • Comments Off on PTIX: Protagenic Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1.81
Enterprise Value ($M) -0.03
Book Value ($M) 1.01
Book Value / Share 0.13
Price / Book 1.78
NCAV ($M) 0.94
NCAV / Share 0.12
Price / NCAV 1.92

Profitability (mra)
Return on Invested Capital (ROIC) -5.45
Return on Assets (ROA) -2.14
Return on Equity (ROE) -2.59

Liquidity (mrq)
Quick Ratio 2.00
Current Ratio 2.00

Balance Sheet (mrq) ($M)
Current Assets 1.88
Assets 1.96
Liabilities 0.94
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -5.70
Net Income -5.53
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -4.22
Cash from Investing 2.80
Cash from Financing 1.96

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Armistice Capital, Llc 3.41 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-31 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A
2024-04-24 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 25,957 207,285 12.52
2025-04-16 9,505 114,145 8.33
2025-04-15 4,584 186,727 2.45
2025-04-14 18,632 193,676 9.62

(click for more detail)

Similar Companies
PRPH – ProPhase Labs, Inc. PRQR – ProQR Therapeutics N.V.
PRTG – Portage Biotech Inc. PTPI – Petros Pharmaceuticals, Inc.
PULM – Pulmatrix, Inc.


Financial data and stock pages provided by
Fintel.io